Compare ABVX & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | LEVI |
|---|---|---|
| Founded | 2013 | 1853 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Apparel |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.1B |
| IPO Year | N/A | 2019 |
| Metric | ABVX | LEVI |
|---|---|---|
| Price | $139.31 | $21.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $115.83 | $26.23 |
| AVG Volume (30 Days) | 1.8M | ★ 1.9M |
| Earning Date | 08-11-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | N/A | ★ 303.84 |
| EPS | N/A | ★ 1.51 |
| Revenue | $6,231,374.00 | ★ $6,589,400,000.00 |
| Revenue This Year | $6.80 | N/A |
| Revenue Next Year | N/A | $5.34 |
| P/E Ratio | ★ N/A | $14.04 |
| Revenue Growth | N/A | ★ 11.22 |
| 52 Week Low | $4.77 | $12.17 |
| 52 Week High | $139.62 | $24.82 |
| Indicator | ABVX | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 43.56 |
| Support Level | $108.53 | $21.74 |
| Resistance Level | $138.49 | $22.62 |
| Average True Range (ATR) | 7.32 | 0.56 |
| MACD | 0.89 | -0.10 |
| Stochastic Oscillator | 91.28 | 0.62 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.